Download Clinical Trials at the Cancer Institute of New Jersey

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Clinical Trials at the Cancer Institute of New Jersey – Hamilton
Currently recruiting participants (updated as of September 17, 2015)
Breast Cancer
SWOG S1007
SWOG S1207
NSABP B-55
ECOG E-2112
Lymphedema
Registry by Stanford
University Medical
Center
Gynecologic
CINJ 130909
Colon
CALGB C80702
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine
Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone
Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score
(RS) of 25 or Less
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of
Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with HighRisk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer
A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre
Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as
Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High
Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive
Local Treatment and Neoadjuvant or Adjuvant Chemotherapy
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in
Men and Postmenopausal Women with Hormone Receptor-Positive Advanced
Breast Cancer
A registry to study breast cancer-related lymphedema. By collecting your health
information, we hope to learn whether early diagnosis will help to prevent
lymphedema or, if it occurs, to reduce the severity.
Psychological Interventions for Gynecologic Cancer
A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus
Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus
A041202
Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>= 65 Years of Age)
With Chronic Lymphocytic Leukemia (CLL)
Cancer Patients and Care givers
The Cancer
A survey for patients and care givers to share their story, that can help bring
Experience Registry knowledge and insights about their social and emotional needs and provide them
Trial
with information on the development of new programs, research and policy.
Adult Patients undergoing a Nipple Sparing Mastectomy
ASBrS Nipple
The American Society of Breast Surgeons would like to use your health
Sparing Mastectomy information in a Nipple Sparing Mastectomy Registry. By placing the health
Registry
information of many patients such as you into a research registry, researchers
will be able to increase their knowledge about breast cancer and answer
questions about breast cancer and its treatment.
For more information, please contact the Research Office at 609-631-6946